Table 1.
Intra-group and inter-group differences in the first follow up (from the beginning of the treatment to 9 months) and in the second follow-up (from the beginning of the treatment to 18 months)
| Calcium hydroxide 9 months |
Biodentine 9 months |
Calcium hydroxide 18 months |
Biodentine 18 months |
Intra-group p- value CH (OR: CI 95%) |
Intra-group p- value Biodentine OR CI 95% |
Inter-group p- value 9 months OR CI 95% |
Inter-group p- value 18 months OR CI 95% |
|
|---|---|---|---|---|---|---|---|---|
| Sex | 91 males, 80 females, | 98 males, 90 females, | 88 males, 75 females, | 94 males, 85 females, | ||||
| Age (years) | 7.7 ± 1.6 | 7.5 ± 1.5 | 7.5 ± 1.5 | 7.6 ± 1.7 | ||||
| Total success | 171 (85.5%) | 188 (94%) | 163 (81.5%) | 179 (89.5%) | 0.28 (1.34: 0.79–2.28) | 0.1 (1.84: 0.88–3.85) | 0.005* (0.38: 0.19–0.76) | 0.02* (0.52: 0.29–0.92) |
| Clinical success | 182 (91%) | 195 (97.5%) | 179 (89.5%) | 193 (96.5%) | 0.61 (1.19: 0.61–2.3) | 0.56 (1.41:0.44–4.53) | 0.005* (0.26: 0.09–0.71) | 0.006* (0.31: 0.13–0.74) |
| Radiographic success | 171 (85.5%) | 188 (94%) | 166 (83%) | 181 (90.5%) | 0.49 (1.21:0.7–2.07) | 0.19 (1.64:0.78–3.48) | 0.005* (0.38: 0.19–0.76) | 0.027* (0.51: 0.28–0.93) |
| Pain | 11 (5.5%) | 2 (1%) | 13 (6.5%) | 3 (1.5%) | 0.67 (0.84:0.37–1.92) | 0.65 (0.66:0.11–4.01) | 0.011* (5.76:1.26–26.34) | 0.01* (4.57: 1.28–16.28) |
| Percussion | 9 (4.5%) | 1 (0.5%) | 9 (4.5%) | 2 (1%) | 1 (1:0.39–2.57) | 0.56 (0.5:0.04–5.53) | 0.01* (9.38:1.18–74.72) | 0.03* (4.66: 1–21.87) |
| Swelling | 12 (6%) | 1 (0.5%) | 12 (6%) | 1 (0.5%) | 1 (1: 0.44–2.28) | 1 (1:0.06–16.1) | 0.002* (12.7:1.64–98.64) | 0.002* (12.7: 1.64–98.64) |
| Mobility | 2 (1%) | 1 (0.5%) | 3 (1.5%) | 1 (0.5%) | 0.65 (0.11–4.01) | 1 (1:0.06–16.1) | 0.56 (2.01:0.18–22.35) | 0.32 (3.03:0.31–29.38) |
| Esfoliation | 16 (8%) | 6 (3%) | 18 (9%) | 9 (4.5%) | 0.72 (0.88:0.43–1.78) | 0.43 (0.66:0.23–1.88) | 0.028* (2.81:1.08–7.34) | 0.07 (2.1:0.92–4.79) |
| Widening | 13 (6.5%) | 5 (2.5%) | 16 (8%) | 8 (4%) | 0.56 (0.8:0.37–1.71) | 0.4 (0.62:0.2–1.91) | 0.054* (2.71: 0.95–7.75) | 0.09 (2.09:0.87–4.99) |
| Resorption | 14 (7%) | 5 (2.5%) | 17 (8.5%) | 8 (4%) | 0.57 (0.81:0.39–1.69) | 0.4 (0.62:0.2–1.91) | 0.034* (2.94:1.04–8.31) | 0.06 (2.23:0.94–5.29) |
| Radiolucency | 2 (1%) | 2 (1%) | 0 (0%) | 3 (1.5%) | 0.16 (0) | 0.65 (0.66:0.11–4.01) | 1 (1:0.14–7.17) | 0.08 (0) |
Chi-square test *p < 0.05